Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.32 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3621170 | 1.00 | ALDH1A1 (0.39) | ALDH1A1THRBMAPTHTTNPSR1 | |
| SCHEMBL13111991 | 0.90 | PTGS2 (0.36) | ALDH1A1P2RX7 | |
| SCHEMBL3466478 | 0.86 | HTT (0.38) | ALDH1A1THRBMAPTHTTNPSR1 | |
| SCHEMBL2559324 | 0.84 | NPSR1 (0.37) | ALDH1A1THRBMAPTHTTNPSR1 | |
| SCHEMBL3466001 | 0.84 | NPSR1 (0.37) | ALDH1A1THRBMAPTHTTNPSR1 | |
| SCHEMBL2553779 | 0.83 | ALDH1A1 (0.38) | ALDH1A1THRBMAPTHTTNPSR1 | |
| SCHEMBL3465705 | 0.83 | ALDH1A1 (0.38) | ALDH1A1THRBMAPTHTTNPSR1 | |
| SCHEMBL3468920 | 0.82 | HTT (0.35) | ALDH1A1THRBMAPTHTTNPSR1 | |
| SCHEMBL2556283 | 0.81 | PTGS2 (0.32) | — | |
| SCHEMBL14674096 | 0.81 | PTGS2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2557927-A1 | FUNGICIDAL MIXTURES I COMPRISING QUINAZOLINES | BASF SE (DE) | 2013-02-20 | — | — | EP | claimed |
| US-20130035229-A1 | FUNGICIDAL MIXTURES I COMPRISING QUINAZOLINES | BASF SE (DE) | 2013-02-07 | — | — | US | claimed |
| WO-2011128843-A1 | FUNGICIDAL MIXTURES I COMPRISING QUINAZOLINES | BASF SE (DE) | 2011-10-20 | — | — | WO | claimed |
| US-20130035229-A1 | FUNGICIDAL MIXTURES I COMPRISING QUINAZOLINES | BASF SE (DE) | 2013-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130035229-A1 | FUNGICIDAL MIXTURES I COMPRISING QUINAZOLINES | CYP1A2, CYP3A7, CYP51A1 | ALDH1A1 1049/4885THRB 4782/4885MAPT 2263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.